Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein

Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein

Novel coronavirus disease 2019 (COVID-19), a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought an unprecedented public health crisis and continues to threaten humanity due to the persistent emergence of new variants. Therefore, developing more ef...

Full description

Bibliographic Details
Main Authors: Taizhen Liang, Shiqi Xiao, Ziyao Wu, Xi Lv, Sen Liu, Meilin Hu, Guojie Li, Peiwen Li, Xiancai Ma
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Viruses
Subjects:
SARS-CoV-2
phenothiazine
entry inhibitor
spike
cathepsin L
Online Access:https://www.mdpi.com/1999-4915/15/8/1666

Similar Items

Similar Items